Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- EMCURE.NSE
- Price
- 1488.70
- Stock movement up
- +30.60 (2.10%)
- Company name
- Emcure Pharmaceuticals Ltd
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 282.22B
- Ent value
- -
- Price/Sales
- 3.22
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 32.44
- Forward P/E
- 24.53
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 49.66%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-03-10
DIVIDENDS
EMCURE.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 32.44 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 27.05 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.22 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 189.57M |
| EPS (TTM) | 45.88 |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 87.62B |
| Gross profit (TTM) | 45.49B |
| Operating income (TTM) | 12.87B |
| Net income (TTM) | 8.70B |
| EPS (TTM) | 45.88 |
| EPS (1y forward) | 60.70 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 51.91% |
| Operating margin (TTM) | 14.69% |
| Profit margin (TTM) | 9.93% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 0.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 0.00 |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 0.00 |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1468.00 |
| Daily high | 1495.00 |
| Daily low | 1442.80 |
| Daily Volume | 208K |
| All-time high | 1570.60 |
| 1y analyst estimate | 1794.83 |
| Beta | - |
| EPS (TTM) | 45.88 |
| Dividend per share | 0.00 |
| Ex-div date | 14 Aug 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EMCURE.NSE | S&P500 | |
| Current price drop from All-time high | -5.21% | -1.98% |
| Highest price drop | -40.68% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -12.39% | -10.84% |
| Avg time to new high | 24 days | 12 days |
| Max time to new high | 328 days | 1805 days |
COMPANY DETAILS
Marketcap
282.22B
Marketcap category
Large-cap
Description
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Employees
6731
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found